[HTML][HTML] Current trends in drug metabolism and pharmacokinetics

Y Li, Q Meng, M Yang, D Liu, X Hou, L Tang… - … Pharmaceutica Sinica B, 2019 - Elsevier
Pharmacokinetics (PK) is the study of the absorption, distribution, metabolism, and excretion
(ADME) processes of a drug. Understanding PK properties is essential for drug development …

Transporter-mediated drug-drug interactions and their significance

X Liu - Drug Transporters in Drug Disposition, Effects and …, 2019 - Springer
Drug transporters are considered to be determinants of drug disposition and effects/toxicities
by affecting the absorption, distribution, and excretion of drugs. Drug transporters are …

Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced in vitro testing

H Koepsell - Expert Opinion on Drug Metabolism & Toxicology, 2021 - Taylor & Francis
Introduction: Organic cation transporters collectively called OCTs belong to three gene
families (SLC22A1 OCT1, SLC22A2 OCT2, SLC22A3 OCT3, SLC22A4 OCTN1, SLC22A5 …

The role of the kidney in drug elimination: transport, metabolism, and the impact of kidney disease on drug clearance

JO Miners, X Yang, KM Knights… - Clinical Pharmacology & …, 2017 - Wiley Online Library
Recent advances in the identification and characterization of renal drug transporters and
drug‐metabolizing enzymes has led to greater understanding of their roles in drug and …

Evaluation of pharmacokinetic drug–drug interactions: a review of the mechanisms, in vitro and in silico approaches

Y Peng, Z Cheng, F Xie - Metabolites, 2021 - mdpi.com
Pharmacokinetic drug–drug interactions (DDIs) occur when a drug alters the absorption,
transport, distribution, metabolism or excretion of a co-administered agent. The occurrence …

Clinical investigation of coproporphyrins as sensitive biomarkers to predict mild to strong OATP1B-mediated drug–drug interactions

A Kunze, EN Ediage, L Dillen, M Monshouwer… - Clinical …, 2018 - Springer
Abstract Introduction Coproporphyrin (CP) I and III have recently been proposed as
endogenous clinical biomarkers to predict organic anion-transporting polypeptide 1B …

Evaluation of transporters in drug development: current status and contemporary issues

SC Lee, V Arya, X Yang, DA Volpe, L Zhang - Advanced Drug Delivery …, 2017 - Elsevier
Transporters govern the access of molecules to cells or their exit from cells, thereby
controlling the overall distribution of drugs to their intracellular site of action. Clinically …

Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion–transporting polypeptides

W Lee, J Ha, Y Sugiyama - Journal of Biological Chemistry, 2020 - ASBMB
The organic anion transporters (OATs) and organic anion–transporting polypeptides
(OATPs) belong to the solute carrier (SLC) transporter superfamily and play important roles …

Renal organic anion transporters in drug–drug interactions and diseases

X Huo, K Liu - European Journal of Pharmaceutical Sciences, 2018 - Elsevier
The kidney plays a vital role in maintaining systemic homeostasis. Active tubular secretion
and reabsorption, which are mainly mediated by transporters, is an efficient mechanism for …

Pharmacokinetic-based drug–drug interactions with anaplastic lymphoma kinase inhibitors: a review

D Zhao, J Chen, M Chu, X Long… - … Design, Development and …, 2020 - Taylor & Francis
Anaplastic lymphoma kinase (ALK) inhibitors are important treatment options for non-small-
cell lung cancer (NSCLC), associated with ALK gene rearrangement. Patients with ALK …